Danaher plans to launch an AI-powered autonomous laboratory at Abcam, combining robotics and technology from across the company to design, build and test antibodies and other molecular tools. Expected to operate at scale in early 2027, the lab aims to accelerate discovery up to eightfold and eventually produce nearly ten times more reagents, while scientists retain key decision-making roles.

Tech· 15h

Facts from Wikidata (CC0). Image by Unknown author via Wikimedia Commons (Public domain).

Abcam

Negócio do Reino Unido

0membros1here now

Pergunte ao Genius Site

Site Jornal

Feed Discussões Sobre

Sort by

Content type

Últimas notícias e discussão sobre Abcam

Sort by

Content type

Abcam· Tech · 10 sources · 15hStory

Danaher Plans AI Lab for Antibody Discovery in 2027

Tech· 15h

Facts from Wikidata (CC0). Image by Unknown author via Wikimedia Commons (Public domain).

Abcam across IJR

Ask Genius by OpenServe about Abcam Create in Studio Build a game Watch videos

About Abcam

Abcam Limited é uma produtora, distribuidora e vendedora de ferramentas de pesquisa de proteínas operando mundialmente em 13 locais com 1.800 funcionários, dos quais 400 trabalham em Pesquisa e Desenvolvimento (P&D). Abcam foi listada na Nasdaq e na Bolsa de Valores de Londres até ser adquirida pela Danaher Corporation em 2023.

members

here now

Country: United Kingdom
Headquarters: Cambridge
Inception: 1998
Website: https://www.abcam.com/en-us

Coverage spread L13 / C31 / R56

Everything about Abcam →

Related journals

Connected

United Kingdom

Live room · 1 here

Be the first in the room — members see you arrive.

Join the room

Related journals

Connected

United Kingdom

Abcam across IJR

Ask Genius by OpenServe about Abcam Create in Studio Build a game Watch videos